We are currently undertaking the following research:

  1. OAsIS study – Optimizing Adherence through Implementation Science Study. 2017-2021 Collaboration with Harvard University – MGH
  2. KAE609 Malaria study. A Phase 2, multi-center, randomized, open-label, dose escalation study to determine safety of single (QD) and multiple (3 QD) doses of KAE609, given to adults with uncomplicated Plasmodium falciparum malaria. 2017